GlassScriptPhysician profile
Lori L Munsie
NPI 1801904867
$1,388.26
in general payments reported to CMS, 2019-2025
16 companies · $39.25 in 2025
The $39.25 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $712 · 2020: $188 · 2021: $295 · 2022: $31.59 · 2023: $123 · 2025: $39.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $161.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $406.38 | 2019-2023 | Otezla |
| Therapeuticsmd, INC. | $283.27 | 2019-2021 | |
| Duchesnay USA Incorporated | $151.62 | 2019 | |
| Gen-Probe Sales & Service, INC. | $127.63 | 2019 | |
| Abbvie INC. | $92.53 | 2019-2021 | |
| Avanos Medical | $82.47 | 2019 | |
| Astellas Pharma US INC | $77.89 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $35.09 | 2021-2022 | |
| Gilead Sciences, INC. | $25.35 | 2025 | Epclusa |
| Hologic Sales and Service, LLC | $18.10 | 2019-2021 | |
| Glaxosmithkline, LLC. | $17.00 | 2021 | |
| Lilly USA, LLC | $15.59 | 2023 | Trulicity, Mounjaro |
| Exeltis, USA INC. | $15.07 | 2021 | |
| Exact Sciences Corporation | $13.90 | 2025 | Cologuard Collection Kit |
| Coopersurgical, INC. | $13.26 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $13.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Munsie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.